Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement
Heart Oct 05, 2017
Masri A, et al. - This study assessed the patients who underwent transcatheter aortic valve replacement (TAVR) to determine the prevalence and factors associated with persistent pulmonary hypertension (PH) and its relationship with long-term mortality. Findings revealed that at 1 month post-TAVR, the persistence of even moderate or greater PH was common and was related to higher all-cause mortality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries